CSL Behring Australia
The Associate Director of CVR leads the design and execution of translational and non-interventional biomarker studies to bridge preclinical research and clinical development. This role involves scientific leadership, cross-functional collaboration with pharmacology and data science teams, and strategic input into global R&D initiatives. The position focuses on understanding disease mechanisms, target validation, and biomarker discovery within cardiovascular and renal therapeutic areas.
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives. We manufacture remedies for rare and serious conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CSL Behring Australia.
CSL Behring Australia didn’t post a salary, so this is our estimate from similar listings.
7% above the average for this role
Senior Director of Translational Research
Verastem
Associate Director, Translational Research Hematology R&D
AstraZeneca
Director of Translational Sciences
Century Therapeutics
Director, Mechanistic Pharmacology
CSL
Director, Translational Immunology
Travere Therapeutics
Senior Director, Biomarker Development, Strategy, and Operations
Zenas BioPharma